Study title:
Meadows-A-T, Silber-J.
Department of Pediatrics, University of Pennsylvania School of Medicine, Philadelphia, PA, United States.
Delayed consequences of therapy for childhood cancer.
Ca-A Cancer Journal for Clinicians {CA-CANCER-J-CLIN}, 1985, Vol/Iss /Pg. 35/5 (271-286).Meadows-A-T, Silber-J.
Department of Pediatrics, University of Pennsylvania School of Medicine, Philadelphia, PA, United States.
Delayed consequences of therapy for childhood cancer.
Ca-A Cancer Journal for Clinicians {CA-CANCER-J-CLIN}, 1985, Vol/Iss /Pg. 35/5 (271-286).
Type of medicine: Medicines containing chemical active substances
|
Therapeutic area: Neoplasms [C04]
|
Brands: Please see report |
MAH holders: Please see report |
Assessment: |
Active substance: PROCARBAZINE |
ATC code: |
Document link:
|
Document date:
|
Study number: |
EudraCT number:
|
Scope of study: Clinical |
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
-
|
-
|
-
|
Y
|
-
|